Story
Nike Stock Downgraded by BofA on Extended Sales Slump Concerns

Summary
Bank of America analysts downgraded Nike to Underperform and cut their price target to $30, warning that the company's sales recovery is now likely delayed until fiscal 2028 amid challenges in North America and China.
Nike (NKE) shares declined more than 2% in premarket trading Friday after Bank of America downgraded the athletic apparel giant to Underperform from Neutral. Analysts cited a significantly delayed sales turnaround, which the bank now believes will not materialize until fiscal 2028.
BofA Slashes Estimates and Price Target
Analysts led by Lorraine Hutchinson lowered their price objective on Nike stock to $30 from $47, projecting negative sales growth for the company through fiscal 2027. The firm's revised outlook represents a stark reversal from a previous expectation of a sales inflection in the spring.
Key revisions from the BofA report include:
- EPS Estimates: Fiscal 2027 and 2028 earnings-per-share estimates were cut by 11% and 12%, respectively. The bank's 2027 EPS forecast is now 14% below the Visible Alpha consensus.
- Valuation Multiple: The new price objective is based on a 16 times price-to-earnings (P/E) multiple, a reduction from 22 times, bringing it in line with the peer average.
- Dividend Concern: BofA also lowered its income rating for the stock, noting a dividend payout ratio that exceeds 100%.
Weakness in Key North American and China Markets
AdThe downgrade is underpinned by weakening trends in Nike's largest markets. In North America, analysts warn that product sell-through at retailers is lagging the rate of sell-in from Nike. They noted that new product launches are failing to meet expectations, which could make retail partners more cautious about future inventory commitments.
In China, a recent field trip by BofA's Luxury Goods team revealed weak consumer demand for sportswear, excess inventory, and new products that are not resonating with customers. The report also stated that Nike's move to reduce its online partner distribution is expected to create promotional pressure in the near term.
Outlook Hinges on Margin and Cost Control
BofA acknowledged that Nike's stock, which has fallen 44% year-to-date against a 12% gain for the S&P 500, already reflects significant cuts to earnings estimates. However, analysts believe it is "unlikely that the stock will hold a premium multiple in the face of further EPS cuts."
With sales under pressure, Nike's earnings outlook now depends heavily on its ability to expand gross margins and control costs. The bank sees some potential for margin improvement from lower tariffs. It also expects Nike's new CFO to make cost-cutting, including reductions in operating overhead, a key focus area.
Read next
More on Stocks
Semiconductor Stocks Surge on AI Demand, Outpacing Broader Market
Semiconductor stocks including Intel, AMD, and Arm Holdings posted double-digit gains this week, driven by sustained investor enthusiasm for artificial intelligence infrastructure. The rally significantly widened the outperformance of AI-focused investment strategies against benchmark indexes like the S&P 500.

Insider Disclosures Show Major Buy at Goosehead, $58M Sale at Aspen Aerogels
Recent SEC filings revealed significant insider transactions, highlighted by a $7.1 million purchase of Goosehead Insurance stock by a major shareholder and a $58.1 million sale of Aspen Aerogels shares by an institutional owner.

Costco Stock Stalls Despite Earnings Beat as High Valuation Weighs on Sentiment
Costco reported quarterly revenue and profit that topped Wall Street estimates, but its shares remained flat as investors focused on a normalizing growth outlook and the stock's premium valuation.

Evonik Shares Surge Over 8% on Report of BASF Merger Approach
Shares in German specialty chemicals firm Evonik Industries jumped after a Financial Times report stated that rival BASF has made a formal merger proposal. The news sparked takeover speculation, pushing the stock to a new 52-week high.